Private Advisor Group’s Palisade Bio PALI Stock Holding History

Private Advisor Group’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-45	Closed	-$3K	–	1886
2022 Q3	$3K	Hold	45	–	–	﹤0.01%	1905
2022 Q2	$14K	Buy	+45	New	+$21.7K	﹤0.01%	2081
2022 Q1	–	Sell	-38	Closed	-$37K	–	2229
2021 Q4	$37K	Buy	38 +7	+23%	+$12.2K	﹤0.01%	2088
2021 Q3	$62K	Buy	31 +3	+11%	+$6.63K	﹤0.01%	1975
2021 Q2	$86K	Buy	+28	New	+$127K	﹤0.01%	1915
2020 Q3	–	Hold	0	–	–	–	2868
2020 Q2	–	Hold	0	–	–	–	3896
2016 Q4	–	Hold	0	–	-$5K	–	1320
2016 Q3	–	Hold	0	–	–	–	1129
2016 Q2	–	Hold	0	–	–	–	1116
2016 Q1	–	Hold	0	–	–	–	1018
2015 Q4	–	Hold	0	–	–	–	1080
2015 Q3	–	Hold	0	–	–	–	1008
2015 Q2	–	Hold	0	–	–	–	1031
2015 Q1	–	Hold	0	–	–	–	966
2014 Q4	–	Hold	0	–	–	–	942
2014 Q3	–	Hold	0	–	–	–	1041
2014 Q2	–	Hold	0	–	–	–	864
2014 Q1	–	Hold	0	–	–	–	774
2013 Q4	–	Hold	0	–	–	–	722

Other funds holding PALI

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Private Advisor Group's PALI Position: Q4 2022 in Review

Private Advisor Group sold out of Palisade Bio (PALI) in Q4 2022, closing a stake of 45 shares — an estimated $3K sold.

Private Advisor Group first reported a position in PALI in Q2 2021 and held it in 5 quarters. The position peaked at $86K in Q2 2021. 11 funds tracked by Wall St. Rank hold PALI as of Q4 2022.

Private Advisor Group reported no remaining Palisade Bio position as of Q4 2022 after selling out during the quarter.
Private Advisor Group sold 45 Palisade Bio shares in Q4 2022, an estimated $3K.
Private Advisor Group first reported a position in Palisade Bio in Q2 2021 and held it in 5 quarters.
Private Advisor Group's Palisade Bio position peaked at $86K in Q2 2021.
11 funds tracked by Wall St. Rank held Palisade Bio as of Q4 2022.

Based on Private Advisor Group's 13F filing for Q4 2022, filed 18 Jan 2023.